Mark A. Kay
Direktor/Vorstandsmitglied bei Genevant Sciences Corp.
Aktive Positionen von Mark A. Kay
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | 01.01.1998 | - |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Direktor/Vorstandsmitglied | 19.11.2018 | - |
| Independent Dir/Board Member | 19.11.2018 | - |
Karriereverlauf von Mark A. Kay
Ehemalige bekannte Positionen von Mark A. Kay
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2016 | 16.11.2022 |
| Gründer | 01.08.2014 | 16.11.2022 | |
| Independent Dir/Board Member | 01.01.2016 | 16.11.2022 | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Gründer | 01.01.2005 | 01.01.2006 |
| Präsident | 01.01.2005 | 01.01.2006 | |
| VOYAGER THERAPEUTICS, INC. | Gründer | 01.06.2013 | - |
Ausbildung von Mark A. Kay
| Michigan State University | Undergraduate Degree |
| Case Western Reserve University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Operativ
| Founder | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Börse
- Insiders
- Mark A. Kay
- Erfahrung